Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 576.33B | 586.53B | 558.06B | 538.03B | 467.94B | 393.57B |
Gross Profit | 164.16B | 164.75B | 159.28B | 145.81B | 138.61B | 111.43B |
EBITDA | 78.79B | 108.86B | 111.40B | 79.08B | 78.89B | 61.01B |
Net Income | 55.67B | 49.48B | 55.83B | 40.68B | 31.25B | 19.71B |
Balance Sheet | ||||||
Total Assets | 861.56B | 813.83B | 839.17B | 765.61B | 698.84B | 640.38B |
Cash, Cash Equivalents and Short-Term Investments | 78.86B | 65.14B | 73.18B | 93.84B | 90.53B | 91.54B |
Total Debt | 309.90B | 280.92B | 299.79B | 317.83B | 280.50B | 267.60B |
Total Liabilities | 466.04B | 438.79B | 464.31B | 455.17B | 419.29B | 395.38B |
Stockholders Equity | 379.17B | 359.99B | 358.90B | 295.21B | 272.02B | 237.85B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 23.44B | 7.52B | -25.08B | -4.48B | 21.08B |
Operating Cash Flow | 0.00 | 93.41B | 76.73B | 26.85B | 42.99B | 57.87B |
Investing Cash Flow | 0.00 | -47.87B | -55.37B | -44.09B | -46.53B | -34.22B |
Financing Cash Flow | 0.00 | -48.85B | -52.37B | 19.96B | -5.45B | -17.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥489.99B | 10.10 | 9.64% | 2.95% | 5.02% | 10.23% | |
77 Outperform | ¥319.91B | 6.64 | 13.58% | 4.98% | 5.10% | -8.39% | |
76 Outperform | ¥375.39B | 19.70 | 6.45% | 0.24% | 6.09% | -10.60% | |
74 Outperform | ¥298.68B | 11.90 | 7.16% | 4.62% | 10.04% | -13.38% | |
71 Outperform | $634.86B | 19.58 | 3.69% | 4.49% | 3.40% | -35.47% | |
69 Neutral | $436.49B | 9.83 | 6.78% | 4.44% | -4.90% | 20.59% | |
62 Neutral | $10.16B | 9.71 | -0.17% | 2.93% | 2.22% | -32.49% |
Daicel Corporation announced corrections to its consolidated financial results for the fiscal year ended March 31, 2025. The corrections pertain to errors found in the investment in equity method investees under the segment information of the financial statements. These adjustments are crucial for accurate financial reporting and may impact stakeholders’ understanding of the company’s financial health.
The most recent analyst rating on (JP:4202) stock is a Buy with a Yen2040.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.
Daicel Corporation announced corrections to its consolidated financial results for the fiscal year ended March 31, 2024. The corrections pertain to errors found in the ‘Investment in equity method investees’ under segment information, which have been rectified to ensure accurate financial reporting. This announcement underscores Daicel’s commitment to transparency and accuracy in its financial disclosures, which is crucial for maintaining stakeholder trust and ensuring proper market positioning.
The most recent analyst rating on (JP:4202) stock is a Buy with a Yen2040.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.
Daicel Corporation announced proposed amendments to its Articles of Incorporation to better align with its current business operations and enhance flexibility in management. These changes aim to allow more directors, including outside directors, to chair meetings, reflecting a strategic shift to adapt to a dynamic business environment.
The most recent analyst rating on (JP:4202) stock is a Buy with a Yen2040.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.
Daicel Corporation has announced its decision to cancel 10 million treasury shares, which constitutes 3.61% of its total shares before cancellation. This move, resolved at a Board of Directors meeting, is expected to impact the company’s share structure by reducing the total number of shares issued to 266,942,682, potentially affecting shareholder value and market perception.
The most recent analyst rating on (JP:4202) stock is a Buy with a Yen2040.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.
Daicel Corporation reported its consolidated financial results for the year ending March 31, 2025, showing a 5.1% increase in net sales to 586,531 million yen. However, the company experienced declines in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 2.2%, 8.9%, and 11.4% respectively. The company also announced an increase in annual cash dividends per share from 50 yen to 60 yen, reflecting a higher dividend payout ratio. Despite the challenges in profits, Daicel’s financial position remains stable with a slight improvement in capital adequacy ratio, indicating resilience in its operations.
The most recent analyst rating on (JP:4202) stock is a Buy with a Yen2040.00 price target. To see the full list of analyst forecasts on Daicel stock, see the JP:4202 Stock Forecast page.